Serum homocysteine in pre-eclampsia and eclampsia

Bangladesh Medical Research Council Bulletin

Volumn 34, Issue 1, 2008, Pages 16-20

  Hoque, Mozammel ^a   Bulbul, Tania ^a   Mahal, Monzarin ^b   Islam, Nur A Farzana ^c   Fcrdausi, Munira ^d  

^a BANGABANDHU SHEIKH MUJIB MEDICAL UNIVERSITY   (Bangladesh)

^b DHAKA MEDICAL COLLEGE   (Bangladesh)

^c North East Medical College ^*  (Bangladesh)

^d RAJSHAHI MEDICAL COLLEGE   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE;

ADULT; ARTICLE; BLOOD SAMPLING; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ECLAMPSIA; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; PREECLAMPSIA; PREGNANCY OUTCOME; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE;

ADULT; BANGLADESH; CASE-CONTROL STUDIES; ECLAMPSIA; FEMALE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; PILOT PROJECTS; PRE-ECLAMPSIA; PREGNANCY; RISK FACTORS;

EID: 48049107728     PISSN: 03779238     EISSN: None     Source Type: Journal    
DOI: 10.3329/bmrcb.v34i1.1165     Document Type: Article

References (37)

1. Roberts JM, Redman CWG. Pre-eclampsia: More than pregnancy induced hypertension. Lancet 1993; 341: 1447-51.
2. Witlin AG, Sibai BM. Magnesium sulfate therapy in pre-eclampsia and eclampsia. Obstet Gynecol. 1998; 92: 883-89.
3. Centers for Disease Control and Prevention: Maternal mortality: United States, 1982-1996. MMWR Morb Mortal Wkly Rep. 1998; 171: 705-07.
4. Gifford R, August P, Chesley L. National high blood pressure education program working group report on high pressure in pregnancy. Am J Obstet Gynecol. 1990; 163: 1689-1712.
5. Scott CL, Chavez GF, Atrash HK, Taylor DJ, Shah RS, Rowley D. Hospitalization for severe complications of pregnancy, 1987-1992. Obstet Gynecol. 1997; 90: 225-29.
6. Cunningham FG, MacDonald PC, Gant NF, Leveno KJ, Gilstrap LC. Williams obstetrics. 20th ed. Cunnecticut; Appletion and Lange, 1997.
7. Abdella TN, Sibai BM, Hays JM, Anderson GD. Relationship of hypertensive disease to abruption placentae. Obstet Gynecol. 1984; 63: 365-70.
8. Dekker G, Sibai B. Etiology and pathogenesis of preeclampsia: Current concepts. Am J Obstet Gynecol. 1998; 179: 1359-75.
9. Roberts J, Taylor R, Musci T, Rodgers G, Hubel C, McLaughlin M. Preeclampsia: An endothelial call disorder. Am J Obstet Gynecol. 1989; 161: 1200-04.
10. Refsum H, Ueland PM, Nygard O, Vollset SE. Homocysteine and cardiovascular disease. Ann Rev Med. 1998; 49: 31-62.
11. Sydow K, Schwedhelm E, Arakawa N, Bode-Boger SM, Tsikas D, Horning B, Frohilch JC, Boger RH. ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocysteinemia: Effects of L-arginine and B vitamins. Cardiovasc Res. 2003; 57: 244-58.
12. Walker MC, Smith GN, Perkins SL, Keely EJ, Garner PR. Changes in homocysteine level in normal pregnancy. Am J Obstet Gynecol. 1999; 180: 660-64.
13. Ray JG, Laskin CA. Folic acid and homocysteine metabolic defects and the risk of placental abruption, pre-eclampsia and spontaneous pregnancy loss: A systemic review. Placenta 1999; 20: 519-29.
14. Dekker G, de Varies J, Doelitzsch P. Underlying disorders associated with severe early-onset preeclampsia. Am J Obstet Gynecol. 1995; 173: 1042-48.
15. Goddijin-Wessel T, Wouters M, vd Molen E. Hyperhomocysteinemia: A risk factor for placental abruption or infarctio. Eur J Obstet Gynecol Reprod Biol. 1996; 66: 23-29.
16. Woters M, Boers G, Trijbels F. Hyperhomocysteinemia: A risk factor in women with unexplained recurrent early pregnancy loss. Fetril Steril. 1993; 60: 820-25.
17. Powers R, Evans R, Majors A. Plasma homocysteine concentration is increased in pre-eclampsia and associated with evidence of endothelial activation. Am J Obstet Gynecol. 1998; 179: 1605-11.
18. Bangladesh Bureau of statistics. Ministry of Planning. 2004, National census 2002.
19. Mabie WC, Sibai BM. Hypertensive states of pregnancy. In: Current obstetric & gynecologic diagnosis & treatment. DeCherney AH, Pernoll ML (eds). 8th ed. USA, Appleton and Lange, 1994, p 388.
20. Rashid KM, Rahman M, Hyder S. Textbook of community medicine and public health. 4th ed. Dhaka, RHM publishers, 2004.
21. Ware-Jauegi S, Sanchez SE, Zhang C, Laraburre G, King IB. Williams MA. Plasma lipid concentrations in pre-eclamptic and normotensive Pruvian women. Int J Obstet Gynecol. 1999; 67: 147-55.
22. Mackey AP, Berg CJ, Atrash HK. Pregnancy related mortality from pre-eclampsia and eclampsia. Obstet Gynecol. 2001; 197: 533-38.
23. Dekker G, Sibai B. Primary, secondary, and tertiary prevention of pre-eclampsia. Lancet 2001; 105: 1177-84.
24. Rajkovic A, Catalano PM, Malinow MR. Elevated homocysteine level with pre-eclampsia. Obstet Gynecol. 1997; 90: 168-71.
25. Zeeman GG, Alexander JM, McIntire DD, Devaraj S, Leveno KJ. Homocysteine plasma concentration levels for the prediction of pre-eclampsia in women with chronic hypertension. Am J Obstet Gynecol. 2003; 189: 574-76.
26. Ingec M, Borekci B, Kadanali S. Elevated plasma homocysteine concentrations in severe pre-eclampsia and eclampsia. Tohoku J Exp Med. 2005; 206: 225-31.
27. Pernet P, Lasnier E, Vaubourdolle M: Evaluation of the AxSYM homocysteine assay and comparison with the IMX homocysteine assay. Clin Chem. 2000; 46: 1440-41.
28. Rajkovic A, Mahomed K, Malinow MR, Sorenson TK, Woelk GB, Williams MA. Plasma homocysteine concentration in eclamptic and pre-eclamptic African women postpartum. Obstet Gynecol. 1999; 94: 355-60.
29. Gurbuz A, Karateke A, Mengulluoglu M. Elevated plasma homocys teine levels in preeclampsia and eclampsia. Int J Gynecol Obstet. 2004; 87: 165-66.
30. Cotter AM, Molloy AM, Scott JM, Daly SF. Elevated plasma homocysteine in early pregnancy: A risk factor for the development of severe preeclampsia. Am J Obstet Gynecol. 2001; 185: 781-85.
31. Sorensen TK, Malinow MR, Williams MA, King IB, Luthy DA. Elevated second trimester serum homocysteine level and subsequent risk for preeclampsia. Gynecol Obstet Invest. 1999; 48: 98-103.
32. Sanchez SE, Zhang C, Rene, Malinow M, Ware-Jauregui S, Laraburre G, Williams MA. Plasma folate, vitamin B12, and homocysteine concentration in preeclamptic and normotensive Peruvian women. Am J Epidemiol. 2001; 153: 474-80.
33. Heilala R, Turpeinen U, Laatikainen T. Serum homocysteine in 16 weeks and subsequent preeclampsia. Obstet Gynecol. 2001; 97: 527-29.
34. Middledrop S, van de Pool MH, Bank L Hamulyak K, Libourel EJ, Koopman MM, Prim MH, van der Meer J, Buller HR. Unselected women with elevated levels of factor VIIIC or homocysteine are not at increased risk for obstetric complications. Thromb Haemost. 2004; 92: 787-90.
35. Strain JJ, Dowey L, Ward M, Pentieva K, McNulty H. B-vitamins, homocysteine metabolism and CVD. Nutrition Society 2004; 63: 597-603.
36. Castro R, Rivera I, Struys EA, Jansen EEW, Ravasco P, Camilo ME, Blom H J, Jakobs C, de Almeida IT. Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease. Clin Chem. 2003; 49: 1292-96.
37. Patrick TE, Powers RW, Daftary AR, Ness RB, Roberts JM. Homocysteine and folic acid are inversely related in black women in pre-eclampsia. Hypertension 2004; 43: 1279.